全身氨甲环酸优化乳房假体置换手术:减少术后失血与引流时间的益处
本研究首次探讨全身氨甲环酸对乳房假体置换联合包膜切除术后失血及出血并发症的影响。将40例(80侧)接受1 g氨甲环酸常规预防的患者与20例(40侧)未接受的历史队列回顾性比较。结果显示氨甲环酸显著减少24小时引流量(72 ml vs 95 ml,24.2%)和总引流量(189 ml vs 351 ml,46.2%),缩短引流时间(3.9天 vs 7.1天,45.1%),并减轻血红蛋白和血细胞比容下降。
要点
- 全身氨甲环酸显著减少24小时引流量(72 ml vs 95 ml,24.2%)。
- 总引流量显著降低(189 ml vs 351 ml,46.2%),引流时间缩短(3.9天 vs 7.1天,45.1%)。
- 血肿发生:氨甲环酸组1例 vs 对照组2例。
核心结论
- 全身给予氨甲环酸可有效减少双侧假体置换联合包膜切除术患者的术后失血和引流时间。
研究设计与样本
- 回顾性比较研究:40例(80侧)接受术中1 g氨甲环酸常规预防的患者与20例(40侧)未接受的历史队列比较。
主要发现
- 氨甲环酸显著减少24小时内引流量(72 ml vs 95 ml,24.2%)和总引流量(189 ml vs 351 ml,46.2%)。
- 氨甲环酸组引流时间显著缩短(3.9天 vs 7.1天,45.1%)。
- 氨甲环酸组术后血红蛋白和血细胞比容下降幅度减小。
- 术后出血并发症:氨甲环酸组发生1例血肿,对照组2例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimising surgical bleeding is crucial for optimising outcomes in clinical practice. Tranexamic acid, an antifibrinolytic agent, has shown efficacy in various clinical fields and is receiving increased attention in plastic and aesthetic surgery. This study is the first to investigate the impact of systemic tranexamic acid on post-operative blood loss and bleeding complications in patients undergoing breast implant replacement with simultaneous capsulectomy for capsular contracture. METHODS: After introducing systemic administration of 1 g tranexamic acid during surgery as routine prophylaxis, 40 patients (80 breasts) receiving this treatment were retrospectively compared to a historic cohort of 20 patients (40 breasts) who did not. The evaluated outcome parameters included 24-hour and total drain fluid production, drain time, and absolute and relative decreases in haemoglobin and haematocrit levels on the first operative day. Furthermore, bleeding complications such as the need for blood transfusion and haematoma evacuation were assessed. RESULTS: Tranexamic acid significantly reduced drainage volume within the first 24 h (72 ml versus 95 ml, 24.2%) and total drain fluid production (189 ml versus 351 ml, 46.2%). Additionally, a significantly shorter drainage time (3.9 d versus 7.1 d, 45.1%) and decreased post-operative decline in haemoglobin and haematocrit levels were observed. Regarding post-operative bleeding complications, 1 haematoma occurred in the tranexamic acid group versus 2 in the control group. CONCLUSION: Systemic administration of tranexamic acid effectively reduced post-operative blood loss and drain time in patients undergoing bilateral implant replacement surgery with capsulectomy.
引用
- Wachtel C, Rothenberger J, Nichlos E, et al. Optimising breast implant replacement surgery: Benefits of systemic tranexamic acid on post-operative blood loss and drain time. J Plast Reconstr Aesthet Surg. 2025. PMID: 40204620. doi:10.1016/j.bjps.2025.02.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。